Efficacy and Safety of a Vaginal Ovule Medical Device for Bacterial Vaginosis and Candidal Vaginitis (ROVUL25). | MicrobiomeTrials← Back to trialsNCT07703241
Efficacy and Safety of a Vaginal Ovule Medical Device for Bacterial Vaginosis and Candidal Vaginitis (ROVUL25).
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-07-09Est. Completion: 2026-11-30
Enrollment target: 80 participants Locations- Clinica Mediterranea, Naples, Italy
Other microbiome trials you might be interested in
Bacterial VaginosisVaginal MicrobiomeChlamydia Trachomatis InfectionNeisseria Gonorrheae InfectionTrichomonas Vaginitis
HIV remains a global pandemic with 37 million infected. In western Kenya, 16% of women in the general population and 29%…
Chicago, United StatesEst. completion Jul 31, 2026
Bacterial InfectionsBacterial Infections and MycosesInfectionsVaginitisVaginal Diseases
Genital Diseases, Female
Female Urogenital Diseases
Urogenital Disease
Candidiasis
Mycoses
Vulvovaginitis
Vulvar Diseases
Vaginosis, Bacterial
In this pilot study, prospectively acquired clinician-collected and participant-collected vaginal swab specimens will be…
North Miami, United StatesEst. completion Dec 2026
Bacterial Vaginosis Treatment
This study is being done to check how safe and comfortable LCFA-01 is when used inside the vagina. LCFA-01 is a natural …
Brisbane, AustraliaEst. completion Aug 12, 2026